MICA and neoplasm: miRNA dysregulation decreases the expression of activating ligands, MICA/B (76, 77) and ULBP2 (76), and increases the expression of inhibitory ligands, PD-L1 (78) and MHC class I molecules (79, 80) on tumour cells, which can limit the immunosurveillance capabilities of NK cells.